Early Ga-68 FAPI PET/MR After Acute Myocardial Infarction
Recruiting
Observational Study
Acute Myocardial Infarction (AMI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Ankara University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Acute myocardial infarction (AMI) initiates a complex myocardial repair process involving inflammation, fibroblast activation, and extracellular matrix remodeling, which may ultimately lead to adverse left ventricular remodeling and impaired cardiac function. Fibroblast activation protein (FAP)-targeted positron emission tomography (PET) enables noninvasive visualization of activated fibroblasts a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years.
* Diagnosis of acute myocardial infarction according to current guideline criteria.
* Successful coronary revascularization when clinically indicated.
* Ability to undergo FAPI PET/MR.
* Written informed consent.
Exclusion Criteria:
* Contraindications to MRI …
Contacts